Coleman County Medical Center Company | |
310 South Pecos Street, Coleman, Texas 76834 | |
(325) 625-2135 | |
Name | Coleman County Medical Center Company |
---|---|
Type | Critical Access Hospital |
Location | 310 South Pecos Street, Coleman, Texas |
Ownership | Government - Hospital District or Authority |
Emergency Services | Yes |
Medicare ID (CCN) | 451347 |
NPI Number | 1154468338 |
Organization Name | COLEMAN COUNTY MEDICAL CENTER |
Address | 310 S Pecos St, Coleman, TX 76834 |
Hospital Type | General Acute Care Hospital - Critical Access |
Phone Number | 325-625-2135 |
News Archive
Speaking at the Institute of Physics conference Physics 2005 in Warwick, scientists will reveal a new test for cancer, more sensitive than any existing technique and capable of predicting for the first time whether a tumour has spread.
People who have contact with other social groups are more likely to be committed to social justice. However, an international study led by the University of Zurich has shown that for this to be the case, power relations and discrimination must be actively addressed and group-specific needs must be met.
Edison Pharmaceuticals today announced that the United States Food and Drug Administration granted Fast Track designation to EPI-743, the company's lead drug, for the treatment of Friedreich's ataxia. EPI-743 is being developed for pediatric and adult mitochondrial disease, including Friedreich's ataxia.
Cells rely on a range of signaling systems to communicate with each other and to control their own internal workings. Scientists from the European Molecular Biology Laboratory (EMBL) in Hamburg, Germany, have now found a way to hack into a vital communications system, raising the possibility of developing new drugs to tackle disorders like neurodegeneration, cancer and cardiovascular disease.
› Verified 3 days ago
NPI Number | 1376681726 |
Organization Name | COLEMAN COUNTY MEDICAL CENTER |
Address | 310 S Pecos St, Coleman, TX 76834 |
Hospital Type | General Acute Care Hospital - Critical Access |
Phone Number | 325-625-2135 |
News Archive
Speaking at the Institute of Physics conference Physics 2005 in Warwick, scientists will reveal a new test for cancer, more sensitive than any existing technique and capable of predicting for the first time whether a tumour has spread.
People who have contact with other social groups are more likely to be committed to social justice. However, an international study led by the University of Zurich has shown that for this to be the case, power relations and discrimination must be actively addressed and group-specific needs must be met.
Edison Pharmaceuticals today announced that the United States Food and Drug Administration granted Fast Track designation to EPI-743, the company's lead drug, for the treatment of Friedreich's ataxia. EPI-743 is being developed for pediatric and adult mitochondrial disease, including Friedreich's ataxia.
Cells rely on a range of signaling systems to communicate with each other and to control their own internal workings. Scientists from the European Molecular Biology Laboratory (EMBL) in Hamburg, Germany, have now found a way to hack into a vital communications system, raising the possibility of developing new drugs to tackle disorders like neurodegeneration, cancer and cardiovascular disease.
› Verified 3 days ago
NPI Number | 1407121189 |
Organization Name | PREFERRED HOSPITAL LEASING COLEMAN, INC. |
Doing Business As | COLEMAN COUNTY MEDICAL CENTER |
Address | 310 S Pecos St, Coleman, TX 76834 |
Hospital Type | General Acute Care Hospital - Critical Access |
Phone Number | 325-625-2135 |
News Archive
Speaking at the Institute of Physics conference Physics 2005 in Warwick, scientists will reveal a new test for cancer, more sensitive than any existing technique and capable of predicting for the first time whether a tumour has spread.
People who have contact with other social groups are more likely to be committed to social justice. However, an international study led by the University of Zurich has shown that for this to be the case, power relations and discrimination must be actively addressed and group-specific needs must be met.
Edison Pharmaceuticals today announced that the United States Food and Drug Administration granted Fast Track designation to EPI-743, the company's lead drug, for the treatment of Friedreich's ataxia. EPI-743 is being developed for pediatric and adult mitochondrial disease, including Friedreich's ataxia.
Cells rely on a range of signaling systems to communicate with each other and to control their own internal workings. Scientists from the European Molecular Biology Laboratory (EMBL) in Hamburg, Germany, have now found a way to hack into a vital communications system, raising the possibility of developing new drugs to tackle disorders like neurodegeneration, cancer and cardiovascular disease.
› Verified 3 days ago
NPI Number | 1437296902 |
Organization Name | COLEMANCOUNTY MEDICAL CENTER |
Address | 310 S Pecos St, Coleman, TX 76834 |
Hospital Type | General Acute Care Hospital - Critical Access |
Phone Number | 325-625-2135 |
News Archive
Speaking at the Institute of Physics conference Physics 2005 in Warwick, scientists will reveal a new test for cancer, more sensitive than any existing technique and capable of predicting for the first time whether a tumour has spread.
People who have contact with other social groups are more likely to be committed to social justice. However, an international study led by the University of Zurich has shown that for this to be the case, power relations and discrimination must be actively addressed and group-specific needs must be met.
Edison Pharmaceuticals today announced that the United States Food and Drug Administration granted Fast Track designation to EPI-743, the company's lead drug, for the treatment of Friedreich's ataxia. EPI-743 is being developed for pediatric and adult mitochondrial disease, including Friedreich's ataxia.
Cells rely on a range of signaling systems to communicate with each other and to control their own internal workings. Scientists from the European Molecular Biology Laboratory (EMBL) in Hamburg, Germany, have now found a way to hack into a vital communications system, raising the possibility of developing new drugs to tackle disorders like neurodegeneration, cancer and cardiovascular disease.
› Verified 3 days ago
NPI Number | 1609909480 |
Organization Name | COLEMAN COUNTY MEDICAL CENTER |
Address | 310 S Pecos St, Coleman, TX 76834 |
Hospital Type | General Acute Care Hospital - Critical Access |
Phone Number | 325-625-2135 |
News Archive
Speaking at the Institute of Physics conference Physics 2005 in Warwick, scientists will reveal a new test for cancer, more sensitive than any existing technique and capable of predicting for the first time whether a tumour has spread.
People who have contact with other social groups are more likely to be committed to social justice. However, an international study led by the University of Zurich has shown that for this to be the case, power relations and discrimination must be actively addressed and group-specific needs must be met.
Edison Pharmaceuticals today announced that the United States Food and Drug Administration granted Fast Track designation to EPI-743, the company's lead drug, for the treatment of Friedreich's ataxia. EPI-743 is being developed for pediatric and adult mitochondrial disease, including Friedreich's ataxia.
Cells rely on a range of signaling systems to communicate with each other and to control their own internal workings. Scientists from the European Molecular Biology Laboratory (EMBL) in Hamburg, Germany, have now found a way to hack into a vital communications system, raising the possibility of developing new drugs to tackle disorders like neurodegeneration, cancer and cardiovascular disease.
› Verified 3 days ago
NPI Number | 1669542312 |
Organization Name | COLEMAN COUNTY MEDICAL CENTER |
Address | 310 S Pecos St, Coleman, TX 76834 |
Hospital Type | General Acute Care Hospital - Critical Access |
Phone Number | 325-625-2135 |
News Archive
Speaking at the Institute of Physics conference Physics 2005 in Warwick, scientists will reveal a new test for cancer, more sensitive than any existing technique and capable of predicting for the first time whether a tumour has spread.
People who have contact with other social groups are more likely to be committed to social justice. However, an international study led by the University of Zurich has shown that for this to be the case, power relations and discrimination must be actively addressed and group-specific needs must be met.
Edison Pharmaceuticals today announced that the United States Food and Drug Administration granted Fast Track designation to EPI-743, the company's lead drug, for the treatment of Friedreich's ataxia. EPI-743 is being developed for pediatric and adult mitochondrial disease, including Friedreich's ataxia.
Cells rely on a range of signaling systems to communicate with each other and to control their own internal workings. Scientists from the European Molecular Biology Laboratory (EMBL) in Hamburg, Germany, have now found a way to hack into a vital communications system, raising the possibility of developing new drugs to tackle disorders like neurodegeneration, cancer and cardiovascular disease.
› Verified 3 days ago
NPI Number | 1740263318 |
Organization Name | COLEMAN COUNTY MEDICAL CENTER |
Address | 310 S Pecos St, Coleman, TX 76834 |
Hospital Type | General Acute Care Hospital - Critical Access |
Phone Number | 325-625-2135 |
News Archive
Speaking at the Institute of Physics conference Physics 2005 in Warwick, scientists will reveal a new test for cancer, more sensitive than any existing technique and capable of predicting for the first time whether a tumour has spread.
People who have contact with other social groups are more likely to be committed to social justice. However, an international study led by the University of Zurich has shown that for this to be the case, power relations and discrimination must be actively addressed and group-specific needs must be met.
Edison Pharmaceuticals today announced that the United States Food and Drug Administration granted Fast Track designation to EPI-743, the company's lead drug, for the treatment of Friedreich's ataxia. EPI-743 is being developed for pediatric and adult mitochondrial disease, including Friedreich's ataxia.
Cells rely on a range of signaling systems to communicate with each other and to control their own internal workings. Scientists from the European Molecular Biology Laboratory (EMBL) in Hamburg, Germany, have now found a way to hack into a vital communications system, raising the possibility of developing new drugs to tackle disorders like neurodegeneration, cancer and cardiovascular disease.
› Verified 3 days ago
NPI Number | 1881817922 |
Organization Name | COLEMAN COUNTY MEDICAL CENTER |
Address | 310 S Pecos St, Coleman, TX 76834 |
Hospital Type | General Acute Care Hospital - Critical Access |
Phone Number | 325-625-2135 |
News Archive
Speaking at the Institute of Physics conference Physics 2005 in Warwick, scientists will reveal a new test for cancer, more sensitive than any existing technique and capable of predicting for the first time whether a tumour has spread.
People who have contact with other social groups are more likely to be committed to social justice. However, an international study led by the University of Zurich has shown that for this to be the case, power relations and discrimination must be actively addressed and group-specific needs must be met.
Edison Pharmaceuticals today announced that the United States Food and Drug Administration granted Fast Track designation to EPI-743, the company's lead drug, for the treatment of Friedreich's ataxia. EPI-743 is being developed for pediatric and adult mitochondrial disease, including Friedreich's ataxia.
Cells rely on a range of signaling systems to communicate with each other and to control their own internal workings. Scientists from the European Molecular Biology Laboratory (EMBL) in Hamburg, Germany, have now found a way to hack into a vital communications system, raising the possibility of developing new drugs to tackle disorders like neurodegeneration, cancer and cardiovascular disease.
› Verified 3 days ago
NPI Number | 1992836894 |
Organization Name | COLEMAN COUNTY MEDICAL CENTER ANESTHESIA GROUP |
Address | 310 S Pecos St, Coleman, TX 76834 |
Hospital Type | General Acute Care Hospital - Critical Access |
Phone Number | 325-625-2135 |
News Archive
Speaking at the Institute of Physics conference Physics 2005 in Warwick, scientists will reveal a new test for cancer, more sensitive than any existing technique and capable of predicting for the first time whether a tumour has spread.
People who have contact with other social groups are more likely to be committed to social justice. However, an international study led by the University of Zurich has shown that for this to be the case, power relations and discrimination must be actively addressed and group-specific needs must be met.
Edison Pharmaceuticals today announced that the United States Food and Drug Administration granted Fast Track designation to EPI-743, the company's lead drug, for the treatment of Friedreich's ataxia. EPI-743 is being developed for pediatric and adult mitochondrial disease, including Friedreich's ataxia.
Cells rely on a range of signaling systems to communicate with each other and to control their own internal workings. Scientists from the European Molecular Biology Laboratory (EMBL) in Hamburg, Germany, have now found a way to hack into a vital communications system, raising the possibility of developing new drugs to tackle disorders like neurodegeneration, cancer and cardiovascular disease.
› Verified 3 days ago
NPI Number | 1992995906 |
Organization Name | COLEMAN COUNTY MEDICAL CENTER |
Address | 310 S Pecos St, Coleman, TX 76834 |
Hospital Type | General Acute Care Hospital - Critical Access |
Phone Number | 325-625-2135 |
News Archive
Speaking at the Institute of Physics conference Physics 2005 in Warwick, scientists will reveal a new test for cancer, more sensitive than any existing technique and capable of predicting for the first time whether a tumour has spread.
People who have contact with other social groups are more likely to be committed to social justice. However, an international study led by the University of Zurich has shown that for this to be the case, power relations and discrimination must be actively addressed and group-specific needs must be met.
Edison Pharmaceuticals today announced that the United States Food and Drug Administration granted Fast Track designation to EPI-743, the company's lead drug, for the treatment of Friedreich's ataxia. EPI-743 is being developed for pediatric and adult mitochondrial disease, including Friedreich's ataxia.
Cells rely on a range of signaling systems to communicate with each other and to control their own internal workings. Scientists from the European Molecular Biology Laboratory (EMBL) in Hamburg, Germany, have now found a way to hack into a vital communications system, raising the possibility of developing new drugs to tackle disorders like neurodegeneration, cancer and cardiovascular disease.
› Verified 3 days ago
Able to receive lab results electronically | Not Available |
Able to track patients' lab results, tests, and referrals electronically between visits | Not Available |
News Archive
Speaking at the Institute of Physics conference Physics 2005 in Warwick, scientists will reveal a new test for cancer, more sensitive than any existing technique and capable of predicting for the first time whether a tumour has spread.
People who have contact with other social groups are more likely to be committed to social justice. However, an international study led by the University of Zurich has shown that for this to be the case, power relations and discrimination must be actively addressed and group-specific needs must be met.
Edison Pharmaceuticals today announced that the United States Food and Drug Administration granted Fast Track designation to EPI-743, the company's lead drug, for the treatment of Friedreich's ataxia. EPI-743 is being developed for pediatric and adult mitochondrial disease, including Friedreich's ataxia.
Cells rely on a range of signaling systems to communicate with each other and to control their own internal workings. Scientists from the European Molecular Biology Laboratory (EMBL) in Hamburg, Germany, have now found a way to hack into a vital communications system, raising the possibility of developing new drugs to tackle disorders like neurodegeneration, cancer and cardiovascular disease.
› Verified 3 days ago
Coleman County Medical Center Company Critical Access Hospital Location: 310 South Pecos Street, Coleman, Texas 76834 Phone: (325) 625-2135 |